The "Global Proteomics Market Size, Share, Growth Analysis, By Product, By Technology, By Application - Industry Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The global proteomics market size was valued at USD 25.2 billion in 2021 and is poised to grow from USD 29.35 billion in 2022 to USD 100.17 billion by 2030, growing at a CAGR of 16.55% in the forecast period (2023-2030).
Companies Mentioned
- Bio-Rad Laboratories, Inc.
- GE Healthcare
- Creative Proteomics
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Danaher Corporation
- Merck KGaA
- Bruker Corporation
- Waters Corporation
- PerkinElmer Inc.
- Shimadzu Corporation
- Biognosys AG
- Luminex Corporation
- Promega Corporation
- Proteome Sciences plc
- Genedata AG
- GenScript Biotech Corporation
- Bioproximity LLC
- Applied Proteomics Inc.
- Avant Diagnostics Inc.
Proteomics is the study of proteins and their structures, functions, and interactions within living organisms. The global proteomics market is driven by the increasing demand for personalized medicine, advancements in proteomics technologies, and the growing focus on drug discovery and development.
The global proteomics market is segmented based on the product, technology, application and region. Based on the product, it is segmented into services, reagents & consumables, and instruments. Based on Technology, it is segmented microarray instruments, x-ray crystallography, spectroscopy, chromatography, protein fractionation systems, electrophoresis, surface plasma resonance (SPR) systems. Based on the application, it is segmented into drug discovery, clinical diagnostics, others. Based on region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Driver
The proteomics market is expected to grow significantly due to various drivers, such as the increasing demand for personalized medicine. Personalized medicine requires a detailed understanding of an individual's protein profile, which has increased the demand for proteomics technologies.
The advancements in proteomics technologies have also contributed to the growth of the market, as new technologies such as mass spectrometry and protein microarrays have enabled rapid and accurate protein analysis. The growing focus on drug discovery and development is another driver of the market, as proteomics technologies are essential for identifying and validating drug targets and evaluating drug efficacy.
Restraint
The high cost of proteomics technologies is a major restraint for the growth of the proteomics market. The complexity of proteomics technologies and the need for specialized equipment and expertise make them expensive, which has limited their adoption in some segments of the healthcare industry.
The lack of standardization and regulatory frameworks is also a challenge, as it hinders the development and commercialization of proteomics technologies.
Market Trends
Biomarker discovery is an emerging trend in the proteomics market, as it enables the identification of protein biomarkers that can be used for disease diagnosis, prognosis, and monitoring.
Proteomics technologies are essential for biomarker discovery, as they enable the analysis of large numbers of proteins in a single sample. The integration of proteomics with genomics is another trend in the market, as it allows for a more comprehensive understanding of disease mechanisms and personalized medicine.
Proteomics and genomics technologies are complementary, as they provide information on different aspects of an individual's biology.
For more information about this report visit https://www.researchandmarkets.com/r/fh5tet
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230530005474/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
